← All verdicts
Verdict

Data Unavailable

Every analyzed stock in Data Unavailable — 2,921 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Data Unavailable" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 3.1% below its 1-year high (as of 2026-09-16). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 7.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 1.2 (undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Probable Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +12.6 pts (1,427 entries, 311 companies, very unlikely to be luck). 50% of entries beat the S&P; 25% beat it by 30 points or more; 30% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +10.9 pts.
+12.6 ptsvs S&P, average
50%beat the S&P
25%up 30+ pts vs S&P
30%down 20+ pts vs S&P
+14.0 ptsvs small caps, 12 mo
−15.1 pts 2019worst year to buy ?
6.1luck check ?
Does the holding period matter?3 mo: +2.3 pts 49% beat6 mo: +4.6 pts 49% beat12 mo: +12.6 pts 50% beat24 mo: +21.8 pts 46% beat3 yr, per yr: +1.3 pts 40% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today1,245+7.9 pts t 4.6+10.1 pts
Sell-off (S&P ≥10% off high)182+44.5 pts t 4.0+40.7 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing466+13.0 pts t 4.0−2.2 pts
Energy126+7.4 pts t 1.2−7.8 pts
Other115+8.4 pts t 1.8+3.8 pts
Tech hardware & semis113+10.9 pts t 1.6+2.3 pts
Services96+11.9 pts t 2.7+12.2 pts
Retail & consumer87+17.2 pts t 2.1+10.2 pts
Finance & real estate72−1.7 pts t -0.5−2.4 pts
Utilities65+5.6 pts t 0.6−1.2 pts
Construction53+13.2 pts t 1.7−2.4 pts
Biotech & pharma44+47.1 pts t 1.6+10.0 pts
Telecom & media43+14.0 pts t 0.7−6.3 pts
Software & IT services35+39.9 pts t 1.8+1.2 pts

Holds up out of sample? Before 2018: +10.7 pts (n 629, t 6.0). From 2018: +14.0 pts (n 798, t 4.1). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+13 pts+5 pts+14 pts+18 pts−4 pts−4 pts+22 pts+12 pts−3 pts−15 pts+87 pts+8 pts+17 pts−9 pts−7 pts+15 pts
n254310610178841118178991297276108121115

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

Sort by: A–Z Riskiest Most overvalued Most shorted Buyers' strike Largest
DOO
BRP Inc.
Valuation N/A
Consumer Cyclical
Price$58.92
Model IV—
P/IV—
Limited data — see page
DPG
Duff & Phelps Utility & Infrastructure Fund Inc.
Valuation N/A
Unknown
Price$13.91
Model IV—
P/IV—
Limited data — see page
DPRO
Draganfly Inc.
Valuation N/A
Industrials Risk 36 · Moderate
Price$5.61
Model IV—
P/IV—
Limited data — see page
DQ
DAQO NEW ENERGY CORP.
Valuation N/A
Technology Risk 40 · Elevated
Price$11.54
Model IV—
P/IV—
Market implies +41.0%/yr vs model +2.0% · above model
DRCT
Direct Digital Holdings, Inc.
Valuation N/A
Technology Risk 47 · Elevated
Price$1.71
Model IV—
P/IV—
Market implies -50.0%/yr vs model +2.0% · below model
DRD
DRDGOLD LTD
Valuation N/A
Basic Materials Risk 41 · Elevated
Price$26.81
Model IV—
P/IV—
Limited data — see page
DRDB
Roman DBDR Acquisition Corp. II
Valuation N/A
Financial Services
Price$10.67
Model IV—
P/IV—
Limited data — see page
DRMA
Dermata Therapeutics, Inc.
Valuation N/A
Healthcare Risk 28 · Moderate
Price$1.19
Model IV—
P/IV—
Limited data — see page
DRTS
Alpha Tau Medical Ltd.
Valuation N/A
Healthcare Risk 42 · Elevated
Price$14.43
Model IV—
P/IV—
Limited data — see page
DRUG
BRIGHT MINDS BIOSCIENCES INC.
Valuation N/A
Healthcare Risk 62 · High
Price$63.38
Model IV—
P/IV—
Limited data — see page
DSAC
Daedalus Special Acquisition Corp.
Valuation N/A
Financial Services
Price$10.17
Model IV—
P/IV—
Limited data — see page
DSGN
Design Therapeutics, Inc.
Valuation N/A
Healthcare Risk 42 · Elevated
Price$14.63
Model IV—
P/IV—
Limited data — see page
DSL
DoubleLine Income Solutions Fund
Valuation N/A
Unknown
Price$10.40
Model IV—
P/IV—
Limited data — see page
DSM
BNY MELLON STRATEGIC MUNICIPAL BOND FUND, INC.
Valuation N/A
Unknown
Price$5.58
Model IV—
P/IV—
Limited data — see page
DSS
DSS, INC.
Valuation N/A
Basic Materials Risk 62 · High
Price$0.72
Model IV—
P/IV—
Market implies +19.1%/yr vs model +3.0% · above model
DSU
BLACKROCK DEBT STRATEGIES FUND, INC.
Valuation N/A
Unknown
Price$9.32
Model IV—
P/IV—
Limited data — see page
DSWL
DESWELL INDUSTRIES INC
Valuation N/A
Consumer Cyclical Risk 32 · Moderate
Price$3.01
Model IV—
P/IV—
Limited data — see page
DSY
Big Tree Cloud Holdings Ltd
Valuation N/A
Basic Materials Risk 53 · Elevated
Price$3.63
Model IV—
P/IV—
Market implies +52.1%/yr vs model +8.0% · above model
DTF
DTF TAX-FREE INCOME 2028 TERM FUND INC
Valuation N/A
Unknown
Price$11.48
Model IV—
P/IV—
Limited data — see page
DTG
DTE ENERGY CO
Valuation N/A
Utilities Risk 46 · Elevated
Price$15.94
Model IV—
P/IV—
Limited data — see page
DTIL
PRECISION BIOSCIENCES INC
Valuation N/A
Healthcare Risk 40 · Elevated
Price$7.17
Model IV—
P/IV—
Market implies +24.1%/yr vs model +2.0% · above model
DTSQ
DT Cloud Star Acquisition Corp
Valuation N/A
Financial Services Risk 42 · Elevated
Price$11.39
Model IV—
P/IV—
Limited data — see page
DTSQR
DT Cloud Star Acquisition Corp
Valuation N/A
Financial Services Risk 40 · Elevated
Price$0.11
Model IV—
P/IV—
Limited data — see page
DTSS
Datasea Intelligent Technology Ltd.
Valuation N/A
Technology
Price$0.66
Model IV—
P/IV—
Limited data — see page
DTST
Data Storage Corp
Valuation N/A
Technology Risk 46 · Elevated
Price$3.04
Model IV—
P/IV—
Market implies +33.1%/yr vs model +2.0% · above model
DUKR
DUKE Robotics Corp.
Valuation N/A
Industrials Risk 31 · Moderate
Price$5.39
Model IV—
P/IV—
Market implies +78.8%/yr vs model +2.0% · above model
DWSN
DAWSON GEOPHYSICAL CO
Valuation N/A
Energy Risk 31 · Moderate
Price$3.22
Model IV—
P/IV—
Market implies +62.0%/yr vs model +8.0% · above model
DWTX
Dogwood Therapeutics, Inc.
Valuation N/A
Healthcare Risk 31 · Moderate
Price$1.94
Model IV—
P/IV—
Limited data — see page
DXF
Eason Technology Ltd
Valuation N/A
Financial Services Risk 33 · Moderate
Price$0.45
Model IV—
P/IV—
Limited data — see page
DXR
DAXOR CORP
Valuation N/A
Unknown Risk 37 · Moderate
Price$11.47
Model IV—
P/IV—
Market implies +45.0%/yr vs model +2.0% · above model
DXYZ
Destiny Tech100 Inc.
Valuation N/A
Unknown
Price$32.11
Model IV—
P/IV—
Limited data — see page
DYAI
DYADIC INTERNATIONAL INC
Valuation N/A
Healthcare Risk 42 · Elevated
Price$0.48
Model IV—
P/IV—
Market implies +20.3%/yr vs model +6.5% · above model
DYN
Dyne Therapeutics, Inc.
Valuation N/A
Healthcare Risk 36 · Moderate
Price$18.21
Model IV—
P/IV—
Limited data — see page
DYNC
Dynamix Corp
Valuation N/A
Financial Services
Price$10.91
Model IV—
P/IV—
Limited data — see page
DYOR
Insight Digital Partners II
Valuation N/A
Financial Services
Price$10.13
Model IV—
P/IV—
Limited data — see page
DZZ
DEUTSCHE BANK AKTIENGESELLSCHAFT
Valuation N/A
Financial Services Risk 32 · Moderate
Price$1.72
Model IV—
P/IV—
Limited data — see page
EAD
ALLSPRING INCOME OPPORTUNITIES FUND
Valuation N/A
Unknown
Price$6.26
Model IV—
P/IV—
Limited data — see page
EAI
ENTERGY ARKANSAS, LLC
Valuation N/A
Utilities Risk 37 · Moderate
Price$19.49
Model IV—
P/IV—
Limited data — see page
EBON
Ebang International Holdings Inc.
Valuation N/A
Financial Services Risk 33 · Moderate
Price$2.13
Model IV—
P/IV—
Market implies +47.1%/yr vs model +2.0% · above model
ECAT
BlackRock ESG Capital Allocation Term Trust
Valuation N/A
Unknown
Price$14.74
Model IV—
P/IV—
Limited data — see page
ECC
Eagle Point Credit Co
Valuation N/A
Unknown
Price$3.65
Model IV—
P/IV—
Limited data — see page
ECCC
Eagle Point Credit Co
Valuation N/A
Unknown
Price$24.90
Model IV—
P/IV—
Limited data — see page
ECCU
Eagle Point Credit Co
Valuation N/A
Unknown
Price$25.45
Model IV—
P/IV—
Limited data — see page
ECCV
Eagle Point Credit Co
Valuation N/A
Unknown
Price$24.15
Model IV—
P/IV—
Limited data — see page
ECF
ELLSWORTH GROWTH & INCOME FUND LTD
Valuation N/A
Unknown
Price$12.51
Model IV—
P/IV—
Limited data — see page
ECG
Everus Construction Group, Inc.
Valuation N/A
Industrials Risk 39 · Moderate
Price$119.42
Model IV—
P/IV—
Market implies +32.6%/yr vs model +9.9% · above model
ECO
Okeanis Eco Tankers Corp.
Valuation N/A
Industrials Risk 42 · Elevated
Price$79.72
Model IV—
P/IV—
Limited data — see page
ECOR
electroCore, Inc.
Valuation N/A
Healthcare Risk 55 · Elevated
Price$9.62
Model IV—
P/IV—
Limited data — see page
EDD
Morgan Stanley Emerging Markets Domestic Debt Fund, Inc.
Valuation N/A
Unknown
Price$5.91
Model IV—
P/IV—
Limited data — see page
EDF
Virtus Stone Harbor Emerging Markets Income Fund
Valuation N/A
Unknown
Price$5.32
Model IV—
P/IV—
Limited data — see page
EDIT
Editas Medicine, Inc.
Valuation N/A
Healthcare Risk 55 · Elevated
Price$2.70
Model IV—
P/IV—
Market implies +46.4%/yr vs model +12.2% · above model
EDSA
Edesa Biotech, Inc.
Valuation N/A
Healthcare Risk 27 · Moderate
Price$4.23
Model IV—
P/IV—
Limited data — see page
EDTK
Skillful Craftsman Education Technology Ltd
Valuation N/A
Consumer Defensive Risk 45 · Elevated
Price$0.93
Model IV—
P/IV—
Market implies +37.7%/yr vs model +2.0% · above model
EDU
New Oriental Education & Technology Group Inc.
Valuation N/A
Consumer Defensive Risk 46 · Elevated
Price$56.26
Model IV—
P/IV—
Market implies +27.0%/yr vs model +3.5% · above model
EEA
EUROPEAN EQUITY FUND, INC / MD
Valuation N/A
Unknown
Price$10.91
Model IV—
P/IV—
Limited data — see page
EEIQ
EpicQuest Education Group International Ltd
Valuation N/A
Consumer Defensive Risk 42 · Elevated
Price$3.62
Model IV—
P/IV—
Market implies +13.2%/yr vs model +13.7% · in line
EFC
Ellington Financial Inc.
Valuation N/A
Real Estate Risk 27 · Moderate
Price$12.89
Model IV—
P/IV—
Limited data — see page
EFOI
ENERGY FOCUS, INC/DE
Valuation N/A
Technology Risk 37 · Moderate
Price$2.74
Model IV—
P/IV—
Market implies +41.3%/yr vs model +2.0% · above model
EFR
Eaton Vance Senior Floating-Rate Trust
Valuation N/A
Unknown
Price$10.42
Model IV—
P/IV—
Limited data — see page
EFT
Eaton Vance Floating-Rate Income Trust
Valuation N/A
Unknown
Price$10.59
Model IV—
P/IV—
Limited data — see page